20
Aurobindo Pharma Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Aripiprazole, Process III, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2020-300 - Rev 00
This Chemical Type CEP, issued on February 18, 2021, remains in force until June 09, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 2617 associated with this CEP further emphasizes